Global Biotech is surging as policy fears fade and innovation takes centre stage. Here’s what’s driving the comeback into ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
Democrats in the House have introduced a new bill that aims to further expand Medicare's ability to negotiate drug prices. | Democrats in the House have introduced a new bill that aims to further ...
With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...
Investor's Business Daily on MSN
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year
Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based business model.
After several notable moves to grow the reach of its biomanufacturing platform in recent months, Antheia is linking arms with ...
Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...
THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM PHILADELPHIA, PA / ACCESS Newswire / ...
Debrief: Solid Rocket Motor Market Heats Up is published in Aerospace Daily & Defense Report, an Aviation Week Intelligence Network (AWIN) Market Briefing and is included with your AWIN membership.
Cytokinetics may be counting down the days until the FDA decides whether to approve its cardiovascular drug aficamten. | ...
When a bioactive molecule occurs in nature at trace levels, traditional extraction often means sifting through mountains of ...
UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback